DSpace at RU >

Browsing by Author Muris, J.J.

Full Text	Issue Date	Title	Author(s)
	2008	Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.	Galen, J.C. van; Muris, J.J.; Giroth, C.P.; Vos, W.; Ossenkoppele, G.J., et al
	2007	Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.	Muris, J.J.; Ylstra, B.; Cillessen, S.A.; Ossenkoppele, G.J.; Kluin-Nelemans, J.C., et al
	2007	Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.	Houdt, I.S. van; Muris, J.J.; Hesselink, A.T.; Kramer, D.; Cillessen, S.A., et al
	2006	Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.	Muris, J.J.; Meijer, C.J.M.; Vos, W.; Krieken, J.H.J.M. van; Jiwa, N.M., et al
	2005	Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.	Muris, J.J.; Cillessen, S.A.; Vos, W.; Houdt, I.S. van; Kummer, J.A., et al
	2004	Immuno-histochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell	Muris, J.J.; Cillessen, S.A.; Vos, W.K.; Houdt, I.S. van; Kummer, J.A., et al
	2004	Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas	Muris, J.J.; Meijer, C.J.; Cillessen, S.A.; Vos, W.K.; Kummer, J.A., et al